Sort   by:  
 Page size 
UnknownCharacteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of DDX3X-TP53.
Not available
S-EPMC10225230 | biostudies-literature
ProteomicsData in support of Proteomic study of diffuse large B-cell lymphoma identifies proteins associated to single drug components of R-CHOP
Diffuse large B-cell lymphoma (DLBCL) is a molecularly and pathogenically heterogenous disease with varying clinical outcomes which is reflected in the substantial group of patients developing relapse/refractory disease (rrDLBCL) after standard treatment with the combinatory regimen R-CHOP. The mole...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD064483 | Pride
Rrdlbcl R-cho Dlbcl 
GenomicsGenetic landscape of relapsed DLBCL
Diffuse large B-cell lymphoma is a heterogenous malignancy that can arise de novo or can result from histologic transformation from indolent lymphomas. Considerable sequencing effort has been placed on determining the mutations that are common at the time of diagnosis in DLBCL but little is known ab...
EGAS00001001553 | EGA
UnknownThe mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs.
Not available
S-EPMC8286604 | biostudies-literature
UnknownCost drivers associated with diffuse large B-cell lymphoma (DLBCL) in Japan: A structural equation model (SEM) analysis.
Not available
S-EPMC9140275 | biostudies-literature
UnknownAcquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype.
Not available
S-EPMC8983450 | biostudies-literature
UnknownMutated RAS-associating proteins and ERK activation in relapse/refractory diffuse large B cell lymphoma.
Not available
S-EPMC8764096 | biostudies-literature
UnknownRelapse timing is associated with distinct evolutionary dynamics in DLBCL.
Not available
S-EPMC10029038 | biostudies-literature
UnknownGenetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.
Not available
S-EPMC8675234 | biostudies-literature
UnknownBendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma.
Not available
S-EPMC8993776 | biostudies-literature
Sort   by:  
 Page size